Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by Bigmac4000on Jun 30, 2023 2:18pm
106 Views
Post# 35522706

RE:New Press Release - FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders

RE:New Press Release - FSD Pharma Inc. Announces Results of Annual General and Special Meeting of ShareholdersWhat is this renaming scheme about? What is the costs tied to renaming a company with 3 stock exchanges and multiple drugs in trials. Should we assume they are going to dump the trials? Are they giving up the pharmacy brand to switch to drink brand. They went from weed gimmick to pharmacy gimmick to drink gimmick. How many new fools will fall for this once they rebrand themselves. Hopefully people google the history and not just the hype of the new name. It's funny, if you look up ADs other scam WCE he also renamed that. It's a trend. Change gimmicks and hope for investors and when that fails change names and start again. When is the RS coming? I'm pretty sure one product is done it's current phase in July. What's the story on results. Was it all a waste to stall while management scoop as many bonuses as possible. This shareholders meeting seems to be about nothing but a stall tactic. 
<< Previous
Bullboard Posts
Next >>